6101
|
|
|
Interactor of little elongation complex ELL subunit 1 |
KIAA0947 |
|
6102
|
|
|
Interactor of little elongation complex ELL subunit 2 |
BRCC1, NARG2 |
|
6103
|
|
|
Inducible T cell costimulator |
AILIM, CD278, CVID1 |
Alzheimer disease, Autoimmune disease, Autoimmune hepatitis, Autoimmune thyroid disease, Basal cell carcinoma, Celiac disease, Common variable immunodeficiency, Melanoma, Cutaneous squamous cell carcinoma, Essential tremor, Graves disease, Hashimoto disease, Hyperthyroidism, Hypothyroidism, T-cell leukemia-lymphoma, Lewy body disease, Non-melanoma skin carcinoma, Obesity, Rheumatoid arthritis, Skin cancer, Skin neoplasms, Systemic lupus erythematosus, Thyroid disease, Diabetes mellitus type 1, Diabetes mellitus type 2, VitiligoView all (11 more) |
6104
|
|
|
Inducible T cell costimulator ligand |
B7-H2, B7H2, B7RP-1, B7RP1, B7h, CD275, GL50, ICOS-L, ICOSL, IMD119, LICOS |
|
6105
|
|
|
Inhibitor of DNA binding 1 |
ID, bHLHb24 |
|
6106
|
|
|
Inhibitor of DNA binding 2 |
GIG8, ID2A, ID2H, bHLHb26 |
|
6107
|
|
|
Inhibitor of DNA binding 3 |
HEIR-1, bHLHb25 |
|
6108
|
|
|
Inhibitor of DNA binding 4 |
IDB4, bHLHb27 |
|
6109
|
|
|
Insulin degrading enzyme |
INSULYSIN |
|
6110
|
|
|
Isocitrate dehydrogenase (NADP(+)) 1 |
HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC, PICD |
Ankylosing spondylitis, Hepatocellular carcinoma, Cholangiocarcinoma, Chordoma, Desbuquois syndrome, Giant cell glioblastoma, Glioma, Gliosarcoma, Myeloid leukemia, Promyelocytic leukemia, Liver failure, Maffucci syndrome, Metaphyseal chondrodysplasia, Metaphyseal enchondromatosis, Oligodendroglioma, Paroxysmal extreme pain disorder, Prostatic neoplasmsView all (2 more) |